{
  "model_name": "anthropic/claude-opus-4.1",
  "model_id": "anthropic/claude-opus-4.1",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean Fever (FMF)\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"E85.0\",\n        \"reasoning\": \"Recurrent episodes of fever, serositis (peritonitis), arthritis, Mediterranean/Middle Eastern ancestry, family history, and self-limiting episodes lasting 2-3 days are pathognomonic for FMF\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Systemic Lupus Erythematosus\",\n            \"confidence\": 0.15,\n            \"icd_code\": \"M32.9\",\n            \"reasoning\": \"Can present with serositis, arthritis, and fever in young women, though episodic nature is less typical\"\n        },\n        {\n            \"name\": \"Adult-Onset Still's Disease\",\n            \"confidence\": 0.10,\n            \"icd_code\": \"M06.1\",\n            \"reasoning\": \"Features fever, arthritis, and elevated inflammatory markers, but lacks typical family history pattern\"\n        },\n        {\n            \"name\": \"Inflammatory Bowel Disease (Crohn's)\",\n            \"confidence\": 0.08,\n            \"icd_code\": \"K50.90\",\n            \"reasoning\": \"Can cause recurrent abdominal pain, fever, and arthritis, but peritoneal signs less common\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent self-limiting episodes lasting 2-3 days\",\n        \"Triad of fever, peritonitis, and arthritis\",\n        \"Family history of similar episodes\",\n        \"Mediterranean/East African ancestry\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"MEFV gene mutation analysis\",\n            \"purpose\": \"Confirm FMF diagnosis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Complete Blood Count with differential\",\n            \"purpose\": \"Assess for leukocytosis during attack\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Serum Amyloid A (SAA)\",\n            \"purpose\": \"Screen for amyloidosis complication\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Urinalysis with protein\",\n            \"purpose\": \"Screen for proteinuria/amyloidosis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANA, anti-dsDNA\",\n            \"purpose\": \"Rule out SLE\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Pain management with NSAIDs\",\n            \"IV fluids for hydration\",\n            \"Obtain interpreter services\",\n            \"Document attack characteristics\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.6mg\",\n                \"route\": \"PO\",\n                \"duration\": \"BID daily, lifelong\",\n                \"rationale\": \"First-line prophylaxis for FMF attacks and amyloidosis prevention\"\n            },\n            {\n                \"drug\": \"Indomethacin\",\n                \"dose\": \"50mg\",\n                \"route\": \"PO\",\n                \"duration\": \"TID during acute attack\",\n                \"rationale\": \"Anti-inflammatory for acute attack management\"\n            }\n        ],\n        \"monitoring\": [\n            \"Response to colchicine therapy\",\n            \"Monthly inflammatory markers initially\",\n            \"Annual proteinuria screening\",\n            \"Attack frequency and severity\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Confirm diagnosis and establish long-term management\"\n            },\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Genetic counseling and family screening\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Persistent proteinuria suggesting amyloidosis\",\n        \"Attack lasting >72 hours\",\n        \"Signs of intestinal obstruction\",\n        \"Failure to respond to colchicine\"\n    ],\n    \"patient_education\": [\n        \"FMF is a genetic condition requiring lifelong treatment\",\n        \"Importance of medication compliance to prevent kidney complications\",\n        \"Family members may need genetic testing\",\n        \"Triggers include stress, infection, menstruation\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1-2 weeks with rheumatology\",\n        \"conditions\": \"Return immediately for attacks lasting >3 days, severe pain unresponsive to medication, or signs of kidney problems\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Need genetic confirmation of MEFV mutations\",\n        \"Response to colchicine therapy not yet established\"\n    ]\n}",
  "timestamp": "2025-08-11T19:21:30.672049",
  "latency": 29.412502765655518,
  "tokens_used": 2159,
  "input_tokens": 943,
  "output_tokens": 1216,
  "error": null,
  "raw_response": {
    "id": "gen-1754932861-MCpZT5keDfltwjcT1187",
    "provider": "Google",
    "model": "anthropic/claude-opus-4.1",
    "object": "chat.completion",
    "created": 1754932861,
    "choices": [
      {
        "logprobs": null,
        "finish_reason": "stop",
        "native_finish_reason": "stop",
        "index": 0,
        "message": {
          "role": "assistant",
          "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean Fever (FMF)\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"E85.0\",\n        \"reasoning\": \"Recurrent episodes of fever, serositis (peritonitis), arthritis, Mediterranean/Middle Eastern ancestry, family history, and self-limiting episodes lasting 2-3 days are pathognomonic for FMF\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Systemic Lupus Erythematosus\",\n            \"confidence\": 0.15,\n            \"icd_code\": \"M32.9\",\n            \"reasoning\": \"Can present with serositis, arthritis, and fever in young women, though episodic nature is less typical\"\n        },\n        {\n            \"name\": \"Adult-Onset Still's Disease\",\n            \"confidence\": 0.10,\n            \"icd_code\": \"M06.1\",\n            \"reasoning\": \"Features fever, arthritis, and elevated inflammatory markers, but lacks typical family history pattern\"\n        },\n        {\n            \"name\": \"Inflammatory Bowel Disease (Crohn's)\",\n            \"confidence\": 0.08,\n            \"icd_code\": \"K50.90\",\n            \"reasoning\": \"Can cause recurrent abdominal pain, fever, and arthritis, but peritoneal signs less common\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent self-limiting episodes lasting 2-3 days\",\n        \"Triad of fever, peritonitis, and arthritis\",\n        \"Family history of similar episodes\",\n        \"Mediterranean/East African ancestry\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"MEFV gene mutation analysis\",\n            \"purpose\": \"Confirm FMF diagnosis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Complete Blood Count with differential\",\n            \"purpose\": \"Assess for leukocytosis during attack\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Serum Amyloid A (SAA)\",\n            \"purpose\": \"Screen for amyloidosis complication\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Urinalysis with protein\",\n            \"purpose\": \"Screen for proteinuria/amyloidosis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANA, anti-dsDNA\",\n            \"purpose\": \"Rule out SLE\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Pain management with NSAIDs\",\n            \"IV fluids for hydration\",\n            \"Obtain interpreter services\",\n            \"Document attack characteristics\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.6mg\",\n                \"route\": \"PO\",\n                \"duration\": \"BID daily, lifelong\",\n                \"rationale\": \"First-line prophylaxis for FMF attacks and amyloidosis prevention\"\n            },\n            {\n                \"drug\": \"Indomethacin\",\n                \"dose\": \"50mg\",\n                \"route\": \"PO\",\n                \"duration\": \"TID during acute attack\",\n                \"rationale\": \"Anti-inflammatory for acute attack management\"\n            }\n        ],\n        \"monitoring\": [\n            \"Response to colchicine therapy\",\n            \"Monthly inflammatory markers initially\",\n            \"Annual proteinuria screening\",\n            \"Attack frequency and severity\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Confirm diagnosis and establish long-term management\"\n            },\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Genetic counseling and family screening\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Persistent proteinuria suggesting amyloidosis\",\n        \"Attack lasting >72 hours\",\n        \"Signs of intestinal obstruction\",\n        \"Failure to respond to colchicine\"\n    ],\n    \"patient_education\": [\n        \"FMF is a genetic condition requiring lifelong treatment\",\n        \"Importance of medication compliance to prevent kidney complications\",\n        \"Family members may need genetic testing\",\n        \"Triggers include stress, infection, menstruation\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1-2 weeks with rheumatology\",\n        \"conditions\": \"Return immediately for attacks lasting >3 days, severe pain unresponsive to medication, or signs of kidney problems\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Need genetic confirmation of MEFV mutations\",\n        \"Response to colchicine therapy not yet established\"\n    ]\n}",
          "refusal": null,
          "reasoning": null
        }
      }
    ],
    "usage": {
      "prompt_tokens": 943,
      "completion_tokens": 1216,
      "total_tokens": 2159
    }
  }
}